Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Outcomes of Epiphysiodesis About the Distal Radius and Distal Ulna.
Journal: Hand (New York, N.Y.)
Published: November 27, 2025
Pharmacist care for attention-deficit/hyperactivity disorder electronic medication refills: A cluster randomized trial.
Journal: Journal of managed care & specialty pharmacy
Published: October 31, 2025
Reliability Risk Mitigation in Advanced Packages by Aging-Induced Precipitation of Bi in Water-Quenched Sn-Ag-Cu-Bi Solder.
Journal: Materials (Basel, Switzerland)
Published: April 30, 2024
Higher labor intensity in US automotive assembly plants after transitioning to electric vehicles.
Journal: Nature communications
Published: April 08, 2024
Synthesis and Characterization of ZnO-Nanostructured Particles Produced by Solar Ablation.
Journal: Materials (Basel, Switzerland)
Published: August 28, 2023
C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.
Journal: Thorax
Published: January 24, 2022
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: August 24, 2021
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.
Journal: medRxiv : the preprint server for health sciences
Published: May 11, 2021
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study.
Journal: Mayo Clinic proceedings
Published: August 03, 2020
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia.
Journal: medRxiv : the preprint server for health sciences
Published: June 27, 2020
Last Updated: 09/26/2026